The role of gut microbiota imbalance in preeclampsia pathogenesis: insights into FMO3-mediated inflammatory mechanisms
Open Access
- 12 December 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1682007
Abstract
Background: Preeclampsia (PE) is a severe pregnancy complication linked to systemic inflammation and metabolic dysregulation. Emerging evidence suggests gut microbiota imbalance may contribute to PE pathogenesis, but the underlying mechanisms remain unclear. This study investigated whether gut dysbiosis triggers PE through flavin-containing monooxygenase 3 (FMO3)-mediated inflammatory pathways. Methods: We transplanted fecal microbiota from PE rats, healthy pregnant (HP) rats, and non-pregnant (NP) rats into antibiotic-treated dysbiotic rats, with a control group receiving normal saline (CON). Additionally, FMO3 expression was inhibited using FMO3-RNAi in parallel groups. We measured blood pressure, urine protein, FMO3 protein and mRNA expression, inflammatory markers, liver and kidney function, embryo resorption rate, and fetal weight. Gut microbiota composition was analyzed by 16S rRNA gene sequencing. The impact of interleukin-8 (IL-8) on trophoblast cell function was assessed using cell counting kit-8 (CCK-8), transwell invasion, and tube formation assays. Results: Rats receiving PE fecal microbiota transplantation (FMT) exhibited a gradual rise in blood pressure post-pregnancy, varying degrees of liver and kidney damage, markedly elevated serum inflammatory cytokines, higher fetal resorption rates, and reduced placental weights. FMO3 protein and mRNA expressions were significantly higher in the PE-FMT group. FMO3 knockdown partially improved these perinatal outcomes. Antibiotic treatment significantly decreased gut microbiota alpha and beta diversity. At the genus level, the PE-FMO3-RNAi group showed increased Escherichia-Shigella and decreased Lactobacillus compared to the PE-CON-RNAi group. In cell experiments, elevated IL-8 levels decreased the viability and invasiveness of HTR-8/SVneo cells and diminished the angiogenic potential of human umbilical vein endothelial cells (HUVECs). Conclusion: A disruption of gut microbiota could result in PE through the FMO3-driven inflammatory response, and targeting FMO3 may prove valuable in treating PE.Keywords
Funding Information
- Fujian Provincial Health Technology Project (2024ZD01005)
- Fujian Provincial Health Technology Project (2023GGA059)
This publication has 54 references indexed in Scilit:
- Hif-1α expression targets the TMA/Fmo3/TMAO axis to participate in gallbladder cholesterol stone formation in individuals living in plateau regionsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2024
- Maternal gut microbiota mediate intergenerational effects of high-fat diet on descendant social behaviorCell Reports, 2022
- Maternal obesity during pregnancy leads to derangements in one-carbon metabolism and the gut microbiota: implications for fetal development and offspring wellbeingAmerican Journal of Obstetrics and Gynecology, 2022
- The etiology of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2022
- Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndromeAmerican Journal of Obstetrics and Gynecology, 2022
- FMO3 and its metabolite TMAO contribute to the formation of gallstonesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2019
- Prevention of Vascular Inflammation by Pterostilbene via Trimethylamine‐N‐Oxide Reduction and Mechanism of Microbiota RegulationMolecular Nutrition & Food Research, 2019
- Physiologically Based Pharmacokinetic Modeling Approach to Predict Drug‐Drug Interactions With Ethionamide Involving Impact of Genetic Polymorphism on FMO3The Journal of Clinical Pharmacology, 2019
- Association of pro‐ and anti‐inflammatory cytokines in preeclampsiaJournal of Clinical Laboratory Analysis, 2019
- The effects of sildenafil citrate on uterine angiogenic status and serum inflammatory markers in an L-NAME rat model of pre-eclampsiaEuropean Journal of Pharmacology, 2017